Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-06
2008-05-06
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S398000, C564S428000
Reexamination Certificate
active
07368448
ABSTRACT:
Compounds of the following formula (I) wherein R1R2, n, Ar1and A2are as defined in the specification, in vivo-hydrolysable precursors thereof, pharmaceutically acceptable salts thereof, the use in therapy and pharmaceutical compositions and methods of treatment using the same. The example compounds are 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives. The compounds are neurokinin 1 (NK1) receptor antagonist and/or serotonin reuptake inhibitors, with medical indications for depression and other disorders
REFERENCES:
patent: 4301163 (1981-11-01), Torossian et al.
patent: 5245080 (1993-09-01), Aubard et al.
patent: 5266599 (1993-11-01), Aubard et al.
patent: 5362756 (1994-11-01), Riviere et al.
patent: 5389686 (1995-02-01), Diop et al.
patent: 94/14767 (1994-07-01), None
patent: WO 94/14767 (1994-07-01), None
patent: WO 01/46167 (2001-06-01), None
Ryckmans, et al., Dual NK1 Antagonists—Serotonin Reuptake Inhibitors as Potential Antidepressants. Part 2: SAR and Activity of Benzyloxyphenethyl Piperazine Derivatives, Bioorganic & Medicinal Chemistry Letters, 12, 3195-3198 (2002).
Genicot, C. et al., “Discovery of orally bioavailable NK1 receptor antagonists”; Bioorg. Med. Chem. Lett. 2003, 13(3), pp. 437-442.
Ryckmans, T. et al., “Dual NK1 antagonists-serotonin reuptake . . . SAR and activity of benzyloxyphenethyl piperazine derivatives”; Bioorg. Med Chem Lett., 2002, 12(21), 3195-3198.
Astrazeneca AB
Lesser Erich
Pepper Hamilton LLP
Wilson James O.
LandOfFree
2-(arylalkoxy)-1-phenylethylamine derivatives as NK 1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(arylalkoxy)-1-phenylethylamine derivatives as NK 1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(arylalkoxy)-1-phenylethylamine derivatives as NK 1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2814154